13 January 2012 - US-based Savient Pharmaceuticals Inc (NASDAQ:SVNT) said today it had appointed David Veitch as president of its European business, effective 16 January.

Veitch has over 24 years of pharmaceutical experience at Bristol Myers Squibb (NYSE:BMY) and SmithKline Beecham Pharmace...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up